ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

HCM Hutchmed (china) Limited

267.50
3.00 (1.13%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hutchmed (china) Limited LSE:HCM London Ordinary Share KYG4672N1198 ORD USD0.10
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  3.00 1.13% 267.50 265.00 267.00 273.00 265.50 266.50 18,840 16:35:28
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 838M 100.78M - N/A 0

Hutchison China Meditech Limited Director's Share Dealing (6335O)

22/08/2017 9:00am

UK Regulatory


Hutchmed (china) (LSE:HCM)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Hutchmed (china) Charts.

TIDMHCM

RNS Number : 6335O

Hutchison China Meditech Limited

22 August 2017

Director's Share Dealing

London: Tuesday, August 22, 2017: Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) has received notifications that Ms Edith Shih, Non-executive Director and Company Secretary, purchased a total of 4,000 American Depositary Shares of the Company ("ADSs", each representing one half of one ordinary share of US$1.00 each in the capital of Chi-Med) at an average price of US$24.99 per ADS on August 18 and 21, 2017.

Following the above purchases, Ms Shih is interested in 100,000 ADSs and 70,000 Ordinary Shares, representing approximately 0.20% of the current issued share capital of Chi-Med.

The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

 
 1      Details of the person discharging managerial responsibilities/person closely associated 
-----  --------------------------------------------------------------------------------------------------------------- 
  a)     Name                                  Ms Edith Shih 
-----  ------------------------------------  ------------------------------------------------------------------------- 
 2      Reason for the notification 
-----  --------------------------------------------------------------------------------------------------------------- 
  a)     Position/status                       Non-executive Director and Company Secretary 
-----  ------------------------------------  ------------------------------------------------------------------------- 
  b)     Initial notification/Amendment        Initial notification 
-----  ------------------------------------  ------------------------------------------------------------------------- 
 3      Details of the issuer, emission allowance market participant, auction platform, auctioneer 
         or auction monitor 
-----  --------------------------------------------------------------------------------------------------------------- 
  a)     Name                                  Hutchison China MediTech Limited 
-----  ------------------------------------  ------------------------------------------------------------------------- 
  b)     LEI                                   2138006X34YDQ6OBYE79 
-----  ------------------------------------  ------------------------------------------------------------------------- 
 4      Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
         each type of transaction; (iii) each date; and (iv) each place where transactions have been 
         conducted 
-----  --------------------------------------------------------------------------------------------------------------- 
  a)     Description of the financial          ADS each representing one half of one Ordinary Share of US$1.00 
         instrument, type of instrument         ADS ISIN: US44842L1035 
         Identification code 
-----  ------------------------------------  ------------------------------------------------------------------------- 
  b)     Nature of the transaction             Acquisition of 4,000 ADSs on August 18 and 21, 2017 at an average price 
                                               of US$24.99 per ADS. 
-----  ------------------------------------  ------------------------------------------------------------------------- 
 
 c)     Price(s) and volume(s)                             Price(s)                             Volume(s) 
-----  ------------------------------------  ------------------------------------  ----------------------------------- 
                                      US$25.00                                                    3,569 
  -------------------------------------------------------------------------------  ----------------------------------- 
                                      US$24.98                                                     100 
  -------------------------------------------------------------------------------  ----------------------------------- 
                                      US$24.99                                                     100 
  -------------------------------------------------------------------------------  ----------------------------------- 
                                      US$24.91                                                     200 
  -------------------------------------------------------------------------------  ----------------------------------- 
                                      US$24.92                                                      31 
  -------------------------------------------------------------------------------  ----------------------------------- 
 
  d)     Aggregated information                Aggregated volume: 4,000 ADSs 
          - Aggregated volume                   Price information: US$24.99 
          - Price 
-----  ------------------------------------  ------------------------------------------------------------------------- 
  e)     Date of the transaction               2017-08-18 - acquisition of 3,769 ADSs 
                                                2017-08-21 - acquisition of 231 ADSs 
-----  ------------------------------------  ------------------------------------------------------------------------- 
  f)     Place of the transaction              Nasdaq Stock Market 
-----  ------------------------------------  ------------------------------------------------------------------------- 
 

About Chi-Med

Chi-Med is an innovative biopharmaceutical company which researches, develops, manufactures and sells pharmaceuticals and healthcare products. Its Innovation Platform, Hutchison MediPharma Limited, focuses on discovering and developing innovative therapeutics in oncology and autoimmune diseases for the global market. Its Commercial Platform manufactures, markets, and distributes prescription drugs and consumer health products in China.

Chi-Med is majority owned by the multinational conglomerate CK Hutchison Holdings Limited ("CK Hutchison") (SEHK: 0001). For more information, please visit: www.chi-med.com.

CONTACTS

 
Investor Enquiries 
Mark Lee, 
 SVP Corporate Finance & Development       +852 2121 8200 
 
U.K. & International Media Enquiries 
Anthony Carlisle, Citigate Dewe Rogerson   +44 7973 611 888 (Mobile)   anthony.carlisle@cdrconsultancy.co.uk 
 
U.S. Based Media Enquiries 
Brad Miles, BMC Communications             +1 (917) 570 7340 (Mobile)  bmiles@bmccommunications.com 
Susan Duffy, BMC Communications            +1 (917) 499 8887 (Mobile)  sduffy@bmccommunications.com 
 
Investor Relations 
Matt Beck, The Trout Group                 +1 (917) 415 1750 (Mobile)  mbeck@troutgroup.com 
David Dible, Citigate Dewe Rogerson        +44 7967 566 919 (Mobile)   david.dible@citigatedr.co.uk 
 
Panmure Gordon (UK) Limited 
Richard Gray / Andrew Potts                +44 (20) 7886 2500 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHLIFEDTIIFFID

(END) Dow Jones Newswires

August 22, 2017 04:00 ET (08:00 GMT)

1 Year Hutchmed (china) Chart

1 Year Hutchmed (china) Chart

1 Month Hutchmed (china) Chart

1 Month Hutchmed (china) Chart

Your Recent History

Delayed Upgrade Clock